5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
CAS: 16506-27-7
Ref. 3D-FB32117
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Información del producto
- Bendamustine
- 1H-Benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 2-Benzimidazolebutyric acid, 5-[bis(2-chloroethyl)amino]-1-methyl-
- 4-[5-[Bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
- 4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid
- 5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid
- ω-[1-Methyl-5-[bis(β-chloroethyl)amino]-2-benzimidazolyl]butyric acid
5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid (BCBA) is an experimental cancer drug that is being investigated for the treatment of a variety of cancers. BCBA inhibits the growth and proliferation of cancer cells by interfering with DNA synthesis and repair. BCBA has been shown to be effective in treating T cell lymphomas, as well as solid tumours such as carcinoma cell lines and breast cancer. The drug has also been used to treat hypersensitivity syndrome in many patients with infectious diseases.
Propiedades químicas
Consulta técnica sobre: 3D-FB32117 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
